cytarabine has been researched along with thiazolidines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baer, MR; Doshi, KA; Huszar, D; Natarajan, K; Perrotti, D; Rassool, FV; Tron, AE; Trotta, R | 1 |
Bando, M; Ikeguchi, S; Kanazawa, M; Kikyo, F; Kondo, R; Mitsumori, M; Nishiuchi, R; Sakaguchi, M; Shiokawa, A; Tanaka, S; Yamada, Y | 1 |
2 other study(ies) available for cytarabine and thiazolidines
Article | Year |
---|---|
Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Cytarabine; DNA Damage; Drug Synergism; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Oxidative Stress; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-pim-1; Reactive Oxygen Species; Signal Transduction; Thiazolidines; Topoisomerase II Inhibitors | 2016 |
Prolyl oligopeptidase participates in the cytosine arabinoside-induced nuclear translocation of glyceraldehyde 3-phosphate dehydrogenase in a human neuroblastoma cell line.
Topics: Cell Death; Cell Nucleus; Cell Survival; Cytarabine; Enzyme Inhibitors; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Proline; Prolyl Oligopeptidases; Thiazolidines; Tumor Cells, Cultured | 2021 |